0000000000255505

AUTHOR

Stefan Hentschel

showing 4 related works from this author

Recent cancer survival in Germany: An analysis of common and less common cancers

2014

The monitoring of cancer survival by population-based cancer registries is a prerequisite to evaluate the current quality of cancer care. Our study provides 1-, 5- and 10-year relative survival as well as 5-year relative survival conditional on 1-year survival estimates and recent survival trends for Germany using data from 11 population-based cancer registries, covering around one-third of the German population. Period analysis was used to estimate relative survival for 24 common and 11 less common cancer sites for the period 2007-2010. The German and the United States survival estimates were compared using the Surveillance, Epidemiology and End Results 13 database. Trends in cancer surviv…

Cancer Researchmedicine.medical_specialtyeducation.field_of_studyRelative survivalColorectal cancerbusiness.industryPopulationCancermedicine.diseaseSurgeryCancer registryProstate cancerOncologyEpidemiologymedicineeducationbusinessMultiple myelomaDemographyInternational Journal of Cancer
researchProduct

Survival for patients with rare haematologic malignancies: Changes in the early 21st century

2017

Abstract Introduction Population-level survival has improved for common haematologic malignancies in the early 21st century. However, relatively few population-level data are available for rare haematologic malignancies. Methods Data were extracted from 12 cancer registries in Germany and the Surveillance, Epidemiology and End Results database in the United States (US). Cases of haematologic malignancies with an incidence of less than 1 per 100,000 were selected for analysis. Period analysis was used to determine 5-year relative survival (RS) for the years 2003–2012, and modelled period analysis was used to determine changes in survival between 2003–2007 and 2008–2012. Results Seven individ…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyPathologyTime FactorsAdolescentAnaplastic LymphomaYoung Adult03 medical and health sciencesRare Diseases0302 clinical medicineGermanyInternal medicineHumansMedicineRegistriesHealthcare DisparitiesYoung adultSurvival analysisAgedMycosis fungoidesRelative survivalbusiness.industryIncidenceIncidence (epidemiology)CancerMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesTreatment OutcomeOncologyHematologic Neoplasms030220 oncology & carcinogenesisFemaleMantle cell lymphomabusinessSEER Program030215 immunologyEuropean Journal of Cancer
researchProduct

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study

2009

The aim of this Study was to estimate cancer incidence rate ratios for Turkish migrants in Hamburg, Germany. We used a name-based approach and identified 1346 cases with Turkish names (as a proxy of Turkish origin) among 140,249 cases of cancer registered in the cancer registry Hamburg during 1990-2005. To estimate the size of the denominator population, we applied the name-based approach to the population of Hamburg as well. The cancer incidence of specific cancer sites was compared between Turkish and non-Turkish cases using incidence rate ratios (IRR), stratified by gender and birth cohort. Our main findings are that cancer of the respiratory organs is diagnosed less frequent among Turki…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesCancer Researchmedicine.medical_specialtyAdolescentTurkeyEpidemiologyTurkishPopulationTurkishPrevalenceEmigrants and ImmigrantsMigrantsYoung AdultBreast cancerNeoplasmsGermanymedicineHumansRegistriesChildeducationAgedAged 80 and overGynecologyeducation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceInfant NewbornInfantsocial sciencesMiddle Agedmedicine.diseaselanguage.human_languageCancer registryOncologyChild PreschoolCohortlanguagepopulation characteristicsNeoplasmFemaleSkin cancerbusinessgeographic locationsDemography
researchProduct

Population Level Survival of Patients with Chronic Myeloid Leukemia in Germany in the Early 21st Century

2012

Abstract Abstract 759 Background: Chronic myeloid leukemia (CML) is a rare but highly treatable form of leukemia. Recent advances in the treatment of CML have dramatically improved survival in clinical trials. Prior work using the Surveillance, Epidemiology, and End Results (SEER) database in the United States (US) suggest that survival on the population level has increased, but still lags behind that seen in clinical trials1. In the past, evaluation of population level survival in other countries has been hampered by the lack of high quality data from a large enough population to evaluate trends in survival in this rare disease. Recently, a collaborative effort between the German Cancer Re…

Pediatricsmedicine.medical_specialtyeducation.field_of_studyRelative survivalbusiness.industryImmunologyAge adjustmentPopulationCancerCell BiologyHematologymedicine.diseaseBiochemistryClinical trialStandard errorEpidemiologymedicinebusinesseducationRare diseaseBlood
researchProduct